(Q54757356)

3 June 2018

title

A quantitative method to detect HBV cccDNA by chimeric primer and real-time polymerase chain reaction. (English)

1 reference

3 June 2018

author name string

Shao Jun-Bin

1

1 reference

3 June 2018

Chen Zhi

2

1 reference

3 June 2018

Ni Wei-Qin

3

1 reference

3 June 2018

Fan Jun

4

1 reference

3 June 2018

publication date

1 September 2003

1 reference

3 June 2018

Journal of Virological Methods

published in

1 reference

3 June 2018

volume

112

1 reference

3 June 2018

issue

1-2

1 reference

3 June 2018

page(s)

45-52

1 reference

3 June 2018

Rebound of hepatitis B virus replication in HepG2 cells after cessation of antiviral treatment

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Hepatitis B virus genome is organized into nucleosomes in the nucleus of the infected cell

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

The molecular biology of the hepatitis B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Hepatitis B virus infection of adult human hepatocytes cultured in the presence of dimethyl sulfoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Therapy of viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Structure of Hepatitis B Dane Particle DNA and Nature of the Endogenous DNA Polymerase Reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Effect of virological response on post-treatment durability of lamivudine-induced HBeAg seroconversion

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Production of hepatitis B virus covalently closed circular DNA in transfected cells is independent of surface antigen synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

In vitro infection of primary cultures of cryopreserved adult human hepatocytes with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Hepatitis B: progress in the last 15 years

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

G1 phase dependent nuclear localization of relaxed-circular hepatitis B virus DNA and aphidicolin-induced accumulation of covalently closed circular DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2803%2900190-3

7 January 2021

10.1016/S0166-0934(03)00190-3

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018